Health ❯Healthcare ❯Clinical Trials ❯Phase 3 Trials

SURMOUNT-OSA

FDA Approves Zepbound as First Medication for Obstructive Sleep Apnea in Adults with Obesity

FDA Approves Zepbound as First Drug Treatment for Sleep Apnea